Medicaments

Medicaments

Refine your search results by using the drop-down menus below, or choose “Advanced Search This List.”

Search By Category
Sort By
  • Includes Credits

    CE Hours: 1.5

    Description: Root canal disinfection is still a challenge among clinicians. Many different disinfection protocols are being proposed with uncertain evidence behind them. Technological advances during the last decade have brought new irrigation solutions and delivery systems for disinfection of the root canal system. This lecture will address the main questions clinicians have and bring evidence-based answers to the most common controversies in endodontic disinfection.

    Learning Objectives: 

    • Evaluate the characteristics and mode of action of the main irrigating solutions
    • Discuss clinical advantages and disadvantages of these innovations
    • Discuss the safety of endodontic devices and procedures

    Bettina R. Basrani D.D.S., M.S.D., Ph.D.

    Dr. Bettina Basrani is Associate Professor and Director of the M.Sc. Endodontics Program at the Faculty of Dentistry, University of Toronto, Canada. With over 30 peer-reviewed publications, textbook chapters, textbooks and abstracts to her credit, she has been a constant contributor to endodontic science and clinical knowledge. Dr. Basrani’s research focuses on intracanal medication and root canal irrigation, including agents and delivery methods.

    Speaker Disclosure 

    In accordance with this policy, I declare that I have NO past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith.

    Brett Gilbert, D.D.S.

    Dr. Brett E. Gilbert graduated from the University of Maryland Dental School in 2001 (DDS) and 2003 (Certificate in Endodontics). He is currently a clinical assistant professor in the Department of Endodontics at the University of Illinois-Chicago, College of Dentistry. He is a past-president of the Illinois Association of Endodontists. Dr. Gilbert is board certified, a Diplomate of the American Board of Endodontics. He was named a top ten young dental educator in America by the Seattle Study Club in 2017. In 2019 he was named to Academic Keys Who’s Who in Dentistry Higher Education (WWDHE). He serves as the director of intellectual wellness for the Dental Mental Network. He is the founder of Access Endo, a global online education platform devoted to Endodontics and direct mentorship of colleagues. Dr. Gilbert lectures on clinical endodontics and wellness. Dr. Gilbert is a partner in U.S. Endo Partners and has a full-time private practice limited to Endodontics in Niles, Illinois.

    Speaker Disclosure 

    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: EdgeEndo (Individual(s) Involved: Self): Honorarium; US Endo Partners (Individual(s) Involved: Self): Other Financial or Material Support, Partner

    Ronald Ordinola-Zapata, DDS, MS, PhD

    Dr. Ronald Ordinola Zapata is an Associate Professor at the Endodontic Division University of Minnesota School of Dentistry. Dr. Zapata completed his Endodontic residency program at the IB Bender Endodontic Division, Albert Einstein Medical Center in Philadelphia, (2018), and a Certificate in Clinical Research at the School of Public Health, University of Minnesota. In 2021 Dr. Zapata achieved the Diplomate status of the American Board of Endodontics. Dr. Zapata enjoys teaching, writing scientific papers, and documenting challenging cases. In his academic career, Dr. Zapata has published more than 100 scientific papers in peer-reviewed journals and lectured internationally in more than 10 countries. Dr. Zapata also serves as Associate Editor of the International Endodontic Journal (UK) and is a member of the Scientific Advisory Board of the Journal of Endodontics (USA).

    Speaker Disclosure 

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

  • Includes Credits

    CE: 1.0

    Description: 

    Antibiotics are useful adjunctive tools in the management of endodontic infections. That said, their overuse and misuse in dentistry and medicine have caused a dramatic increase in the rates of antibiotic resistance. The rise in resistance, among other concerns, underscores the need for stewardship of this valuable resource. Participants in this webinar will understand the diagnosis of endodontic infections, but will more importantly appreciate those situations that may benefit from antibiotic therapy as well as those where antibiotics may not be necessary. Evidence-based strategies for prescription will be reviewed, as will antibiotic premedication in dentistry. 

    At the conclusion of this presentation, participants will be able to:         

    • Define antibiotic stewardship and discuss its necessity.
    • Review the diagnosis of orofacial infections
    • Discuss indications and contraindications for antibiotic therapy in endodontic infection management, as well as evidence-based antibiotic regimens. 

    Rebekah Lucier Pryles, D.M.D.

    Dr. Rebekah Lucier Pryles received her DMD and her certificate in Endodontics from Tufts University School of Dental Medicine. She is a private practitioner at Upper Valley Endodontics in White River Junction, VT. She is a Diplomate of the American Board of Endodontics and a fellow in both the American and International Colleges of Dentistry. She continues to be involved in teaching and research and holds a faculty appointment at her alma mater as well as at the Harvard School of Dental Medicine. She co-founded Pulp Nonfiction Endodontics with Dr. Brooke Blicher, an educational collaborative grounded in evidence-based continuing education. She was awarded the ADA’s 10 Under 10 Award in for 2020. Dr. Lucier Pryles is involved in organized dentistry, and is the immediate past President of the Vermont State Dental Society. Together wtih Dr. Brooke Blicher, Dr. Lucier Pryles has published extensively including the textbook, Endodontics: A Review, currently available in its second edition.

    Speaker Disclosure

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

    Brooke Blicher, DMD, Certificate in Endodontics

    Dr. Brooke Blicher received her BA in Chemistry from Colgate University, where she graduated Magna Cum Laude and Phi Beta Kappa, her DMD from the Harvard School of Dental Medicine where she graduated with honors in research, and her certificate in Endodontics from Tufts University School of Dental Medicine.

    Dr. Blicher is a Diplomate of the American Board of Endodontics, and a Fellow in both the American College of Dentistry and the International College of Dentistry.  She continues to be involved with teaching, research and mentorship, holding faculty appointments at both Harvard and Tufts Schools of Dental Medicine. Dr. Blicher has been involved in organized dentistry as a member of several committees for the American Association of Endodontists, and her local and state dental societies. 

    While providing state of the art specialty care in her private practice in White River Junction, Vermont, Dr. Blicher continues to pursue her academic interests.  She authored the chapter “Diagnosis and Treatment Planning” in the 6th edition of Endodontics: Principles and Practice, as well as the textbooks  Endodontics: A Review, now in its second edition, and the newly published Clinical Endodontics, available in March.  She has published extensively, including in the Journal of Dental Research, General Dentistry, Inside Dentistry, and Compendium. Dr. Blicher has lectured both locally and internationally on endodontic diagnosis, non-odontogenic pain, fractures, trauma, resorption, treatment of immature teeth, and CBCTs in endodontics as well as on ideal restorative care following endodontic treatment.

     

    Speaker Disclosure

    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: Quintessence Publishing (Individual(s) Involved: Self): other financial or materials support.

  • Product not yet rated Includes Credits

    CE Hours: 1.0

    Description: The anterior maxillary infiltration is one of the more painful dental injections. The Dentapen is an electronic syringe that uses computer-controlled delivery technology to administer dental local anesthesia at a slow controlled rate. The purpose of this prospective, randomized, single-blind study was to evaluate solution deposition pain of a maxillary lateral incisor infiltration using the Dentapen with the slow flow rate (1.8 mL/162 sec) and ramp-up setting compared with a traditional syringe infiltration at a flow rate of 1.8 mL/60 sec.

    Discuss the influence of solution deposition speed on pain.

    Explain the influence gender has on reported injection pain.

    Describe the preference of injection of type by the study population.


    Leigh Yarborough O'Neal, DMD, MS,

    John Nusstein, DDS, MS

    Dr. John Nusstein is a tenured Professor and the Chair of the Division of Endodontics at The Ohio State University College of Dentistry in Columbus, Ohio.

    Melissa Drum, DDS, MS

    Dr. Drum received her DDS from the University of Minnesota and her endodontic certificate/master's degree from The Ohio State University. She teaches at the dental student and resident levels and is the Advanced Endodontic Program Director and past Predoctoral Endodontic/Emergency Clinic Director.  Dr. Drum is active in service at the college, state and national levels and is a full tenured professor.  She has published more than 80 articles, multiple book chapters, and coauthored a book. Dr. Drum became a Diplomate of the ABE in 2008 and is currently a Director and President of the ABE.  She was named holder of the Al Reader Endowed Professorship in 2013.  Dr. Drum received the AAE Edward M. Ostetek Award in 2014 as well as numerous local teaching and research awards over the years.  Dr. Drum hates writing and reading bios and is much more fun than this paragraph describes.

    Sara Fowler, DMD, MS

    Dr. Sara Fowler received her DMD from the University of Nevada Las Vegas School of Dental Medicine, a graduate of the school’s inaugural class. A native of Columbus, Ohio, Dr. Fowler returned to complete post-graduate training at The Ohio State University College of Dentistry, first with a General Practice Residency, followed by Endodontic Fellowship, and Advanced Endodontic Residency. After working in private practice, Dr. Fowler returned to teach at Ohio State and is now an Associate Professor with tenure in the Division of Endodontics. She is the director of Predoctoral Endodontics and the Emergency Dental Care Clinic, maintains private practice in the Ohio State Dental Faculty Practice, and actively participates in teaching and research with the Advanced Endodontic Residency Program.

    Disclosure:

    In accordance with this policy, I declare that I have NO past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith.

    Al Reader, DDS, MS

    Dr. Al Reader is a Professor in the Division of Endodontics and is a previous program director of Advanced Endodontics at the The Ohio State University.

    Ai Ni, PHd

  • Includes Credits

    CE Hours: 1.0

    Description:  The purpose of this study was to review evidence-based recommendations for the safe perioperative management of patients undergoing endodontic microsurgery who are currently taking antiplatelet or anticoagulant medications. Using the PICO (Population, Intervention, Comparison, Outcome) format, the following scientific question was asked: In patients taking anticoagulant or antiplatelet agents, what is the available evidence in the management of endodontic microsurgery?

    • Discuss the mechanism of action of different classes of drugs in antiplatelet and anticoagulant agents
    • Discuss the difference between perioperative management of major and minor surgeries
    • Discuss the local measures that could be utilized to promote hemostasis

    Anita Aminoshariae, DDS, MSc

    Dr. Anita Aminoshariae is a professor (with tenure) and director of Predoctoral Endodontics at Case Western Reserve University. Her dental career commenced when she was accepted to the Pre-Professional Scholars Program, Six-Year Dentistry at Case School of Dental Medicine. She then worked as a contract dentist for the United States Navy. She obtained her endodontic training, certificate and masters from Virginia Commonwealth University in 2003. She became a Diplomate of the American Board of Endodontics in 2005. Dr. Aminoshariae is a member of the American Dental Association, Ohio Dental Association Ohio Association of Endodontists andthe Council of Scientific Affairs (ADA). She is a spokesperson on the topic of opioids in dentistry (ADA) and asite visitor, Commission on Dental Accreditation (CODA). She has served on the American Association of Endodontists’ Board of Directors and as president of the Greater Cleveland Dental Society. She is a member of the Scientific Advisory Boards for the Journal of Endodontics and Journal of the American Dental Association and is an associate editor for the Journal of Endodontics. Dr. Aminoshariae has published numerous articles in the field of endodontics and evidence-based dentistry.

    Mark Donaldson, BSP, PHARMDACPR, FASJP, FACHE,†‡

    Michael Horan, MD, DDS, PhD, FACS

    James C. Kulild, D.D.S., M.S.

    Dale Baur, DDS

  • Includes Credits

    CE Hours: 1.75

    Description: Substance use disorders have an enormous impact on individuals, families and communities. The National Institute of Drug Abuse reports that there are more deaths, illness and disabilities from substance use than from any other preventable health condition. In fact, one in four deaths in our country is attributable to prescription or illicit drugs, alcohol or tobacco (NIDA 2017). The management of patients with substance use disorders can be challenging, especially if the patients are experiencing pain. This presentation is designed to present the latest information on Substance Use Disorders with a focus on patient management.

    • Prescribe appropriate analgesics for patients with severe opioid use disorder.
    • List common "red flags" that might prompt questioning for patients trying to obtain controlled substances.
    • Define terminology used when treating patients with SUD.

    Amol Patwardhan, MD, PhD

    Amol Patwardhan MD, PhD obtained his medical degree from University of Mumbai and PhD in pharmacology from the UT Health Science Center at San Antonio under Dr. Kenneth Hargreaves. He went on to undergo anesthesiology residency and a chronic pain fellowship at the University of Arizona and UCSD respectively. His doctoral and postdoctoral work focused on the peripheral mechanisms of opioid and cannabinoid analgesia and discovery of a new class of endogenous TRP channel ligands, namely oxidized linoleic acid metabolites. After finishing his clinical training, he joined as a faculty in the departments of anesthesiology and pharmacology at the University of Arizona and is now an Associate Professor and Vice Chair of Research in the department of Anesthesiology. His current research projects include advancing a conotoxin for spinal treatment of intractable pain, repurposing of TRPV1 antagonists for the treatment of intraoperative hypothermia and human studies using various interventions including implanted devices to reduce opioid usage and improve function.

    Michael O'Neil, Pharm.D.

    Dr. O’Neil received his Doctor of Pharmacy from the University of North Carolina at Chapel Hill, NC. Dr. O’Neil has more than 25 years of practice experience in intensive care medicine, emergency medicine, surgery and pain management in several leading medical institutions. He has completed research and published in a variety of health profession journals and books including medicine, pharmacy, dentistry and nursing. Dr. O’Neil was editor and lead author for the American Dental Association’s book titled “The ADA Practical Guide to Substance Use Disorders and Safe Prescribing” published in 2015. Recent scholarship includes co-editing and primary authorship for the text “The Pharmacist Guide to Opioid Use Disorders” in 2018 and 5 articles in the California Dental Association’s special edition journal in March of 2019 Titled “Opioids-Navigating the Perfect Storm”. For more than 25 years, Dr. O’Neil has served as consultant and expert on prescription drug misuse and diversion for several entities including the DEA, the Bureaus of Criminal Investigation, the US Attorney’s Office, and Boards of Osteopathic Medicine, Board of Dental Examiners, the American Association of Dental Boards and several local law enforcement agencies. Dr. O’Neil developed the West Virginia Pharmacist Recovery Network where he served as Executive Director and Investigator. Dr. O’Neil developed and chaired the West Virginia Controlled Substance Advisory Board and was the founding president of the West Virginia Chapter of the National Association of Drug Diversion Investigators.Dr. O’Neil is currently a Professor and the Chair of the Dept. of Pharmacy Practice at South College School of Pharmacy in Knoxville, TN. .

    Amol Patwardhan, MD, PhD
    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: Boston Scientific (Self) : Grant/Research Support (Status: Ongoing); Catalina Pharma (Self) : Stockholder/Ownership Interest (excluding diversified mutual funds) (Status: Ongoing); Solis Therapeutics (Self) : Grant/Research Support (Status: Terminated --- 2020)

    Michael O'Neil, Pharm.D.
    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

  • Includes Credits

    CE: 1.5

    Course Description: 

    The presentation will address the extent of harm of opioid epidemic and addiction in general within the US. The presentation will also review the role of the dental profession in causing this epidemic and explain how the profession can be part of solution going forward.

    At the conclusion, participants should be able to:

    • Describe the extent of harm of the opioid epidemic in the US.
    • Explain the role of doctors and dentists in the opioid epidemic.
    • Describe post-operative dental pain and an evidence-based approach to its management.

    Omar Abubaker, D.MD

    Dr. A. Omar Abubaker earned a Bachelor of Dental Surgery degree (BDS) from the Faculty of Dentistry, University of Alexandria, Alexandria, Egypt in 1975. In 1984 he earned a Ph.D. in Anatomical Sciences and in 1990 earned a Doctor of Dental Medicine (DMD) degree. Between 1984 and 1990 he also served as resident and Chief resident in Oral and Maxillofacial Surgery and one-year research fellowship at the Presbyterian University Hospital in Pittsburgh. Dr. Abubaker was joined the faculty of the Department of Oral and Maxillofacial Surgery in the School of Dentistry, Virginia Commonwealth University (VCU) in July 1991 with the rank of assistant professor. Since 2002, he has served as the Chairman of the Department of Oral and Maxillofacial Surgery, Chief of Division of Surgery in the Department of Surgery, VCU School of Medicine . Dr. Abubaker co-authored two textbooks, over 50 chapters and over 40 scientific articles in peer-review journals. He presented before many local, national and international scientific meetings.. Dr. Abubaker recently earned a Graduate Certificate in International Addiction Studies from the International Program in Addiction Studies from a joint program at Virginia Commonwealth University, The University of Adelaide, and Australia and Kings College London, England. He has interest in education and research in the field of addiction. He lectured to local and national groups on addiction, pain management and opioid epidemic. Over the past two years he presented on the topic of substance use disorder, pain management and opioid epidemic to more than 50 local, regional and national groups and organizations.

    Omar Abubaker, D.MD

    I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: Pacira Pharmaceutical (Self) : Consultant (Status: Ongoing)

  • Includes Credits

    CE: 1.0

    Course Description: 

    Controversies exist in clinical and pharmacologic aspects of endodontics. For example, a recent study raised doubts about the benefits of incision and drainage for patients with fluctuant swellings of endodontic origin. However, incision and drainage has historically been the standard treatment for that condition. An assessment of the research and its significance for clinicians will be discussed. The appropriate use of opioids in dentistry continues to be a critical issue. In the face of an opioid epidemic, dentists have turned to over-the-counter analgesics. However, acetaminophen, ibuprofen and other NsAIDs have been associated with serious side reactions that are of concern especially when used by pregnant patients. These medications have been linked to childhood asthma/wheezing, behavioral problems, hyperkinetic activity and the incidence of myocardial infarcts. Another controversy concerning NsAIDS and acetaminophen is their value in pre meditating patients with irreversible pulpitis prior to inferior alveolar nerve blocks. The clinical implications of these controversies will be discussed.

    At the conclusion, participants should be able to:

    • Evaluate current evidence for Incision and dreaianage in patients with swelling.
    • Discuss recent research concerning complications associated with acetaminophen and ibuprofen.
    • Describe factors to be considered in selecting analgesics for pregnant patients.

    Paul Rosenberg, DDS

    Dr. Paul Rosenberg served as Professor and Chair of the Department of Endodontics, Director of the Advanced Education Program and Director of the International Program, at New York University College of Dentistry from 1990-2012. He was Associate Dean for Graduate Programs from 2000-2005.

    He is a past Director of the American Board of Endodontics 2002-2008 and was a member of the Scientific Advisory Board of the Journal of Endodontics. He has published extensively in journals and textbooks and has lectured nationally and internationally on Endodontic pain. His textbook titled, Endodontic Pain: Diagnosis, Causes, Prevention and Treatment, was published in 2014 by Springer.

    In 2000 Dr. Rosenberg won the Distinguished Teaching Award, which is the highest award for teaching at NYU. In December 2007, NYU College of Dentistry unveiled a new facility, the Paul and Maxine Rosenberg Educational Wing in his honor, dedicated to providing post-graduate students with a facility devoted to their specific needs.

    In 2017 Dr. Rosenberg received the I.B. Bender Lifetime Educator Award from the American Association of Endodontics. The award acknowledges contributions in the field of education.

    Dr. Rosenberg continues to serve as a Professor in the Department of Endodontics.

    Disclosure

    In accordance with this policy, I declare that I have NO past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith.

    Paul A. Rosenberg, D.D.S.

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

  • Includes Credits

    CE: 1.5

    Course Description: 

    The accepted management for any pulpal intervention on a highly inflamed dental pulp is the pulpectomy and root canal treatment. However, it has been shown that radicular pulp has a reparative potential and interesting immune defense properties. A full pulp chamber pulpotomy and filling with a dedicated material could therefore be considered as an alternative treatment. Its feasibility, known on decidual and immature permanent teeth (where it is a routine treatment) is now investigated on mature permanent teeth as a permanent treatment.

    The aim of this lecture is to discuss the rationale behind this hypothesis and the scientific background that could encourage us (or not) to consider the pulp chamber pulpotomy as a predictable endodontic treatment. Our clinical experience will be faced to the literature and both will be used to discuss.

    At the conclusion, participants should be able to:

    • Examine the inflammation status of the pulp as a key factor for clinical decision making.
    • Choose the appropriate endodontic treatment regarding the advancement of the pulp disease.
    • Cite clinical criteria to select the pulp capping procedure or the pulp chamber one.

    Stephane Simon, D.D.S., Ph.D., D.Sc.

    Stéphane SIMON has been qualified as Doctor in Dental Surgery in 1994 at the University of Reims. He got a certificate in Biomaterials in 1998 (University of Paris 7) and in Endodontology in 2000 (Paris 7). He taught Endodontics from 2001 to 2005 at the University of Paris 7 as Assistant Professor, and from 2006 to 2008 at the University of Birmingham (United Kingdom) as a Clinical lecturer. In 2006, he left France for joining Birmingham’s Dental School team for two full years; there, 90% of his time was devoted to research, and 10% to clinical practice and teaching, as a Clinical Lecturer and Associate Specialist in Endodontics. He also got a Master Degree (MPhil) in Molecular and cell Biology in 2005 (Paris 7), and completed in 2009 his PhD in Pulp Biology in the frame of a co-supervised Thesis between the University of Paris 7 and the University of Birmingham. He is also the President of the Publ Biology and Regeneration Group of the IADR and member of the education committee of the European Society of Endodontology. To date he is full time academic teacher/researcher and his clinical practice is limited to Endodontics. He has been graduated as a Senior lecturer in the departments of Oral biology and endodontics and is the director of the Postgraduate Endodontic Program at Paris Diderot University (3 years full time program). His time is 50% devoted to the clinical practice and 50% to Basic Science research about Tissue engineering and dental Pulp. He works as a Researcher in Paris and as Associate Researcher in Birmingham.

    Stephane RJD. Simon, D.D.S, M.Phil, PhD

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

  • Includes Credits

    CE: 1.5

    Course Description: 

    This evidence-based course is designed to provide effective and practical strategies for managing acute dental pain emergencies. The latest information on NSAIDS, acetaminophen-containing analgesics and local anesthetics will be provided with the objective of having immediate application to your next patient emergency. Want to know how to anesthetize that hot tooth? How to predictably manage severe acute pain after surgical or endodontic treatments? How to combine common medications to improve analgesia? This course will answer these practical tips and more using a lecture style that emphasizes interactions with the audience in answering common pain problems with useful solutions.

    At the conclusion, participants should be able to:

    • Describe a fast and efficient routine for managing dental pain emergency patients.
    • Select the best combination of analgesics to manage dental pain.
    • Provide effective local anesthesia to the classic “hot” molar case.

    Kenneth Hargreaves, D.D.S., Ph.D.

    Ken Hargreaves received his DDS from Georgetown University, his PhD in physiology from the Uniformed Services University of the Health Sciences in Bethesda, MD, and his certificate in Endodontics from the University of Minnesota. Ken spent 5 years at the Pain Clinic of the NIDCR and 7 years as an associate professor of Endodontics and Pharmacology at the University of Minnesota. He joined the University of Texas Health Science Center at San Antonio in 1997, as professor and Chair of the Department of Endodontics and is cross-appointed as professor in the Departments of Pharmacology, Physiology and Surgery in the Medical School. He maintains a private practice limited to endodontics and is a Diplomate of the American Board of Endodontists. Ken has received an NIH MERIT Award for research, two IADR Distinguished Scientist Awards, the ADA Gold Medal for Research and the Louis I. Grossman Award from the AAE. He has published more than 190 articles and, with Harold Goodis and Frank Tay, co-edited the 2nd edition Seltzer and Bender’s Dental Pulp, and, with Lou Berman, co-edited the 11th edition of Cohen’s Pathways of the Pulp. Ken also serves as editor of the Journal of Endodontics.

    Speaker Disclosure: 

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation

    Ellen Byrne, D.D.S., PhD

    Dr. B. Ellen Byrne’s academic background includes a bachelor of science in pharmacy, doctor of dental surgery, general practice residency, Certificate in Endodontics and a Ph.D. in pharmacology and toxicology, all from Virginia Commonwealth University. She is currently a professor of endodontics and senior associate dean of the VCU School of Dentistry. Dr. Byrne has authored several chapters in the ADA's "Guide to Dental Therapeutics," is a past member of the Joint Commission on National Dental Board Examinations, a member on the Committee for the Integrated National Board Dental Examination, a curriculum consultant for the Commission on Dental Accreditation and has won multiple alumni awards for teaching and service. She is a fellow in the International College of Dentists, American College of Dentists and Pierre Fauchard Academy. She is a past member of the AAE research and scientific affairs committee and the ADA Council on Scientific Affairs. She is a gifted and entertaining speaker on pharmacology, and has presented at national meetings such as the AAE, ADA, and the Hinman Dental meeting.

    Nikita Ruparel, D.D.S., M.S., Ph.D.

    Dr. Ruparel is Board certified Endodontist who practices in San Antonio at UT Faculty Endodontics. She is the Director of the Advanced Program in Endodontics at UT San Antonio. She received her certificate in Endodontics in 2013 after receiving her doctoral (PhD) and DDS at The University of Texas Health Science Center at San Antonio. Her practice in Endodontics includes all aspects of modern endodontics. She also lectures at national and international meetings on pain biology and management and regenerative endodontics. She has also been awarded the American Association of Endodontics Educator Fellowship for committing her career to academics. Nikita Ruparel is committed to a long-term career as a clinician-scientist.

    Speaker Disclosure

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

    Ellen Byrne, D.D.S., PhD
    Ken Hargreaves, DDS, PhD
    Nikita Bharat. Ruparel, MS, DDS, PhD

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

  • Includes Credits

    CE: 1.5

    Course Description: 

    Neurologic injury as an outcome of endodontic treatment can have devastating consequences for both the patient and the endodontist. Mishaps that occur during the therapeutic stages of endodontic therapy can result in neurologic damage with an unpredictable course and an uncertain prognosis. Dr. Gluskin will discuss the evidence and best practices regarding neurologic injury as a result of endodontic care. He will review the data for prognosis and how to determine treatment and intervention strategies as a result of the chemical harm from overfill. Dr. Gregg will discuss orofacial neuroanatomy, the spectrum of trigeminal nerve injuries, differential diagnosis of post-trauma, neuropathic pain sequelae (peripheral and central), and especially surgical, non-surgical and rehabilitative interventions with outcome expectations.

    At the conclusion, participants should be able to:

    • Describe the sequelae of obturation overfill into neurovascular anatomy and the potential for injury.
    • Explain the differential diagnosis of post-traumatic neuropathic pain sequelae from endodontic overfill that occurs both peripheral and central.
    • Recognize surgical, non-surgical and rehabilitative interventions with outcome expectations.

    Alan H. Gluskin, D.D.S.

    Alan H. Gluskin DDS is currently Professor, Department of Endodontics, Arthur A. Dugoni School of Dentistry, University of the Pacific in San Francisco, California. He served as Chairperson of the Endodontic Department for over thirty years. He is at present a Fellow of the International College of Dentists and the American College of Dentists. Dr. Gluskin has served on numerous AAE committees including the Educational Affairs Committee and the Research and Scientific Affairs Committee, as well being General Chair for both AAE10 and AAE18. Dr. Gluskin has just completed his tenure on the Executive Board of Directors of the American Association of Endodontists as Immediate Past President of the AAE. He additionally functions on the editorial boards of the Journal of Endodontics and the International Journal of
    Endodontics. Dr. Gluskin is the 2017 recipient of the University of the Pacific’s Eberhardt Teacher-Scholar Award. He is co-editor of the textbooks Decision Making in Dental Treatment Planning and Practical Lessons in Endodontic Treatment.

    Speaker Disclosure
    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

    John M. Gregg, D.D.S. M.S. Ph.D

    Currently, Dr. John M. Gregg is Adjunct Professor of Oral & Facial Surgery, Virginia Commonwealth University School of Dentistry and Virginia Tech Carilion School of Medicine Department of Surgery, and is a Diplomat of the American Board of Oral and Maxillofacial Surgery. He received his dental degree at The University of Michigan as well as Doctor of Philosophy in Neuroanatomy at the UM medical school where he also completed his Residency training. His career has included broad spectrum orofacial surgery practices spanning 48 years, national and international lecturing, and multiple academic appointments. Dr. Gregg’s major clinical and research interests have related to trigeminal nerve injuries and associated neuropathic pain. He has been instrumental in the development of microsurgical management of nerve injuries and his work is documented in over 100 peer-reviewed publications, textbook chapters and book editing. He lives on a farm in the Southwest mountains of Virginia, enjoys backpacking, cycling and improvisational jazz trumpet.

    Alan H. Gluskin, D.D.S.

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

    John M. Gregg, D.D.S. M.S. Ph.D

    Nothing to Disclose